Natrecor Lyophilisate For Solution For Injection 1.5Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Natrecor: Lyophilisate for solution for injection (1.5mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

NESIRITIDE, BNP is a vasodilator. This medicine increases the blood and oxygen supply to your heart by relaxing blood vessels. It is used to treat congestive heart failure in patients who experience shortness of breath when at rest or during small amounts of activity.

In-Depth Information

Natrecor 1.5mg Powder for Injection

NDC: 658470205
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Heart Failure

Storage Information
Protect from light
Do not freeze
Store below 77 degrees F
Natrecor 1.5mg Powder for Injection

Reported Side Effects for Natrecor 1.5mg Powder for Injection

Coughing Up Blood Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Diaphoresis Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Confusion Incidence:
>1.0%*
Severity: MODERATE
Onset: EARLY
Injection Site Reaction Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Decreased Breathing Incidence:
>1.0%*
Severity: SEVERE
Onset: DELAYED
Vomiting Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Muscle Cramps Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Stomach Pain Incidence:
1.0%*
Severity: MILD
Onset: EARLY
Paresthesias Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Shaking Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Itching Incidence:
>1.0%*
Severity: MILD
Onset: RAPID
Skin Rash Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
>1.0%*
Severity: MODERATE
Onset: RAPID
Fever Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Drowsiness Incidence:
>1.0%*
Severity: MILD
Onset: EARLY
Cough Incidence:
>1.0%*
Severity: MILD
Onset: DELAYED
Slow Heart Beat Incidence:
1.0%*
Severity: SEVERE
Onset: RAPID
Irregular Heart Beat Incidence:
>1.0%*
Severity: SEVERE
Onset: EARLY
Anemia Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Lazy Eye Incidence:
>1.0%*
Severity: MODERATE
Onset: DELAYED
Inability To Sleep Incidence:
2.0%*
Severity: MILD
Onset: EARLY
Low Blood Sugar Incidence:
>2.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
2.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
3.0%*
Severity: MILD
Onset: EARLY
Back Pain Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Rapid Heart Rate Incidence:
3.0%*
Severity: SEVERE
Onset: EARLY
Abnormal Heart Rhythm Incidence:
3.0%*
Severity: MODERATE
Onset: EARLY
Nervousness Incidence:
3.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
7.0%*
Severity: MILD
Onset: EARLY
Low Blood Pressure Incidence:
7.1-11.0%*
Severity: MODERATE
Onset: RAPID
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

SECOND Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

THIRD Trimester

Class C - Animal studies have shown an adverse effect and there are no adequate and well-controlled studies in pregnant women. OR No animal studies have been conducted and there are no adequate and well-controlled studies in pregnant women.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Natrecor

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5